GlassScriptPhysician profile
Stephen Peter Duquette
NPI 1538507025
$1,435.77
in general payments reported to CMS, 2019-2025
11 companies · $241 in 2025
The $241 reported for 2025 was less than what a typical Surgery of The Hand (Plastic Surgery) provider received nationally (typical 2025 total: $312).
See the full distribution for Surgery of the Hand (Plastic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2021: $114 · 2022: $73.31 · 2023: $325 · 2024: $577 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,143.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $361.73 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Arthrex, INC. | $219.29 | 2019-2021 | |
| Axogen | $216.80 | 2023-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Ha+ Nerve Protector |
| Medwest Associates | $185.00 | 2022-2023 | |
| Trimed, INC. | $178.99 | 2024-2025 | |
| Acumed LLC | $74.06 | 2024 | Inframe Implant, Innate Implant, Acumed |
| Checkpoint Surgical, INC | $66.90 | 2025 | Checkpoint Stimulators |
| Ossur Americas, INC. | $54.96 | 2024 | I-Digits Quantum |
| Linvatec Corporation | $28.43 | 2023 | Biobrace 23mm, Linvatec Extremities |
| Stryker Corporation | $26.91 | 2025 | Latitude Ev |
| Abbott Laboratories | $22.70 | 2025 | Proclaim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Duquette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.